𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Another reason to look for tumor suppressor genes on chromosome 21

✍ Scribed by Daniel Satgé; Annie J. Sasco; Aimé Geneix; Paul Malet


Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
23 KB
Volume
21
Category
Article
ISSN
1045-2257

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Evidence for multiple tumor suppressor g
✍ John B. Sunwoo; Matthew S. Holt; Diane M. Radford; Courtney Deeker; Steven B. Sc 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 576 KB

Loss of heterozygosity studies of a variety of human tumors suggest that there are several tumor suppressor genes on chromosome arm 8p. To localize these genes more precisely. we utilized polymerase chain reaction amplification of microsatellie repeat polymorphism and examined the allelic IOU patter

High frequency of deletion on chromosome
✍ Geetha Perinchery; Nikola Bukurov; Koichi Nakajima; James Chang; Long-Cheng Li; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 293 KB 👁 1 views

Chromosome 9p has been reported to be a critical region of loss in various cancers. Our present study was designed to determine the frequency of deletions at different loci of chromosome 9p in microdissected samples of normal prostatic epithelium and carcinoma from the same patients. For this purpos

Alterations of BLU, a candidate tumor su
✍ Xiao-Qiong Liu; Han-Kui Chen; Xiao-Shi Zhang; Zhi-Gang Pan; Ang Li; Qi-Sheng Fen 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 518 KB

## Abstract Nonrandom allelic loss on chromosome 3p is a common event in nasopharyngeal carcinoma (NPC) with the implication that certain tumor suppressor gene(s) in this region are involved in the pathogenesis of these tumors. The __BLU__ gene, located at 3p21.3, has recently been identified as a

Human cell lines engineered for tetracyc
✍ Alexei I. Protopopov; Jinfeng Li; Gösta Winberg; Rinat Z. Gizatullin; Vladimir I 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 310 KB

## Abstract ## Background We modified a tetracycline‐regulated system that can control the activity of individual genes quantitatively and reversibly in transgenic mammals. Despite these advances, there remained one problem in the intensive use of the tet‐system: the limited range of acceptor cell